CTS
CTS's revenue rose 5.2% to $541 million in fiscal 2025. Its operating margin was 15.3%, up from 13.8% a year earlier. Free cash flow was $86 million, up 8.5%. It paid out $61 million in dividends and buybacks, 71% of free cash flow. The diluted share count fell 3.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What CTS does
CTS makes sensors, connectivity components and actuators, which are devices that make things move. It sorts them as Sense, Connect and Move. Sense products include controls, pedals, piezo sensing products, sensors, switches and transducers. Connect products include filters, capacitors, frequency control products and resistors. Move products include piezo microactuators and rotary actuators.
It sells mostly to makers of equipment and to tier one suppliers (companies that supply parts directly to those makers), as well as distributors and the U.S. Government. Its end markets are transportation, industrial, medical and aerospace and defense, and transportation is its largest, though a smaller share than in 2024. It sells mainly through its own sales engineers, and also through independent manufacturers' representatives and distributors.
CTS was established in 1896 and is based in Lisle, Illinois. It runs manufacturing plants in North America, Asia and Europe and has sales offices in China, the Czech Republic, Denmark, Germany, Japan, Singapore, Taiwan and the United States.
Its biggest risks, as it describes them
- Losing or seeing a big cut in business from a major customer.
- Downturns in cyclical industries it sells to.
- Tariffs, supply chain limits and inflation, and geopolitical conflict.
- Lower end-customer demand, leaving its plants underused.
- Contracts that may be suspended, canceled or delayed, and acquisitions that may not work as planned.
Income statement
From fiscal 2016 to 2025, earnings per share grew 8.7% a year and net income 7.4% a year, as buybacks cut the share count by 11%.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 142 | 157 | 164 | 94 | 82 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | 36.2x | 42.4x | 22.5x | 16.8x | 19.2x |
| Current ratio | 2.5x | 2.9x | 3.3x | 2.5x | 2.3x |
| Quick ratio | 2.1x | 2.3x | 2.7x | 1.9x | 1.8x |
Cash flow
Projections
Project CTS's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 7, 2025 and November 6, 2026, no insider bought CTS shares on the open market, and 2 insiders sold $9.8 million, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Kieran M O'SullivanPresident & CEO, Director | Sold plan | 22,657 | $66.67 | $1.5 million | Form 4 |
| Jun 2, 2026 | Kieran M O'SullivanPresident & CEO, Director | Sold plan | 60,388 | $66.26 | $4.0 million | Form 4 |
| Jun 1, 2026 | Kieran M O'SullivanPresident & CEO, Director | Sold plan | 46,955 | $63.31 | $3.0 million | Form 4 |
| Feb 2, 2026 | Ashish AgrawalCFO | Sold plan | 25,000 | $53.00 | $1.3 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 7.2% | 9.0% | 21.1% |
| Altman Z'' | 7.88 | 6.98 | 7.72 |
| Accruals ratio | −3.8% | −5.7% | −4.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Fail | Pass |
| F-score | — | — | — |
Compare
Put CTS side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| CTS | FY25 | 5.2% | 15.3% | 16.0% | — | — | — | |
| IPG Photonics | FY25 | 2.7% | 1.3% | −0.3% | 0.8% | −10.5x | 7 | Compare |
| Kimball Electronics | FY26 | −3.7% | 4.6% | 1.4% | 5.6% | 0.3x | 8 | Compare |
| Benchmark Electronics | FY25 | 0.1% | 2.9% | 3.3% | 3.7% | −0.9x | 6 | Compare |
| TTM Technologies | FY25 | 19.0% | 9.1% | −0.0% | 10.7% | 1.1x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 397 | 423 | 470 | 469 | 424 | 513 | 587 | 550 | 515 | 541 |
| Revenue growth | 3.8% | 6.6% | 11.2% | −0.3% | −9.6% | 20.9% | 14.4% | −6.2% | −6.5% | 5.2% |
| Gross profit | 140 | 140 | 165 | 158 | 139 | 185 | 210 | 191 | 188 | 208 |
| Research and development | 24 | 25 | 25 | 26 | 24 | 24 | 24 | 25 | 23 | 25 |
| Operating income | 63 | 38 | 61 | 54 | 45 | 76 | 93 | 75 | 71 | 83 |
| Net income | 34 | 14 | 46 | 36 | 35 | −42 | 60 | 60 | 56 | 65 |
| Diluted EPS (US$) | 1.03 | 0.43 | 1.39 | 1.09 | 1.06 | −1.30 | 1.85 | 1.92 | 1.81 | 2.19 |
| Diluted shares (millions) | 33 | 33 | 34 | 33 | 33 | 32 | 32 | 32 | 31 | 30 |
| Cash flow | ||||||||||
| Cash from operations | 47 | 58 | 58 | 64 | 77 | 86 | 121 | 89 | 98 | 102 |
| Capital expenditure | 20 | 18 | 28 | 22 | 15 | 16 | 14 | 15 | 19 | 16 |
| Free cash flow | 27 | 40 | 30 | 43 | 62 | 70 | 107 | 74 | 80 | 86 |
| Dividends paid | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Share buybacks | 0 | 0 | 9 | 12 | 8 | 9 | 21 | 41 | 43 | 56 |
| Acquisitions | 73 | 19 | 0 | 74 | 8 | 0 | 97 | 3 | 122 | 0 |
| Stock-based compensation | — | — | — | — | — | — | — | — | — | — |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 114 | 114 | 101 | 100 | 92 | 142 | 157 | 164 | 94 | 82 |
| Debt incl. finance leases | — | — | — | — | — | — | — | — | — | — |
| Total assets | 518 | 540 | 548 | 643 | 626 | 664 | 748 | 741 | 765 | 764 |
| Total liabilities | 200 | 196 | 170 | 238 | 202 | 201 | 242 | 214 | 237 | 212 |
| Shareholders' equity | 318 | 344 | 378 | 405 | 424 | 464 | 506 | 527 | 528 | 552 |
| Margins and ratios | ||||||||||
| Gross margin | 35.4% | 33.2% | 35.1% | 33.6% | 32.8% | 36.0% | 35.9% | 34.7% | 36.4% | 38.4% |
| Operating margin | 15.9% | 9.1% | 13.0% | 11.5% | 10.6% | 14.9% | 15.8% | 13.6% | 13.8% | 15.3% |
| Net margin | 8.7% | 3.4% | 9.9% | 7.7% | 8.2% | −8.2% | 10.2% | 11.0% | 10.8% | 12.1% |
| Free cash flow margin | 6.7% | 9.4% | 6.3% | 9.1% | 14.6% | 13.7% | 18.2% | 13.5% | 15.5% | 16.0% |
| Rule of 40 (growth + FCF margin) | 10.5% | 16.1% | 17.5% | 8.8% | 5.0% | 34.7% | 32.6% | 7.2% | 9.0% | 21.1% |
| Return on capital | — | — | — | — | — | — | — | — | — | — |
| Return on equity | 11.5% | 4.4% | 12.9% | 9.2% | 8.4% | −9.4% | 12.3% | 11.7% | 10.5% | 12.1% |
| Return on assets | 6.9% | 2.7% | 8.6% | 6.1% | 5.5% | −6.5% | 8.4% | 8.1% | 7.4% | 8.5% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |